Edition:
United Kingdom

BioCryst Pharmaceuticals Inc (BCRX.OQ)

BCRX.OQ on NASDAQ Stock Exchange Global Select Market

7.16USD
19 Oct 2018
Change (% chg)

$-0.03 (-0.42%)
Prev Close
$7.19
Open
$7.18
Day's High
$7.50
Day's Low
$7.08
Volume
172,305
Avg. Vol
208,658
52-wk High
$8.13
52-wk Low
$4.12

Select another date:

Tue, May 8 2018

BRIEF-Biocryst Pharmaceuticals Q1 Loss Per Share $0.26

* Q1 EARNINGS PER SHARE VIEW $-0.19 -- THOMSON REUTERS I/B/E/S

BRIEF-BioCryst Receives European Medicines Agency Approval For Alpivab For Treatment Of Influenza

* BIOCRYST RECEIVES EUROPEAN MEDICINES AGENCY APPROVAL FOR ALPIVAB™ FOR TREATMENT OF INFLUENZA Source text for Eikon: Further company coverage:

Select another date: